2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1774
Neoplasms
1501
Carcinoma, Non-Small-Cell Lung
1043
Prostatic Neoplasms
957
Colorectal Neoplasms
878
Lung Neoplasms
800
Pancreatic Neoplasms
572
Carcinoma, Hepatocellular
542
Leukemia, Myeloid, Acute
541
Stomach Neoplasms
512
Ovarian Neoplasms
507
Neoplasm Metastasis
496
Multiple Myeloma
495
Recurrence
413
Melanoma
386
Squamous Cell Carcinoma of Head and Neck
370
Brain Neoplasms
362
Uterine Cervical Neoplasms
361
Head and Neck Neoplasms
355
Esophageal Neoplasms
312
Precursor Cell Lymphoblastic Leukemia-Lymphoma
310
Lymphoma
305
Endometrial Neoplasms
304
Triple Negative Breast Neoplasms
299
Glioblastoma
298
Rectal Neoplasms
280
Urinary Bladder Neoplasms
264
Sarcoma
264
Hematologic Neoplasms
264
Colonic Neoplasms
254
Interventions
padeliporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Transitional Cell Cancer of Renal Pelvis and Ureter
×
Clear all
NCT04620239
2026-02-04
UCM301
Steba Biotech S.A.
Phase 3
Recruiting
100 enrolled